Fig. 1
source: GSE 55,235); (E) typical western blot images and quantitative analysis of TDO2 protein expression in NSF (n = 3) and OA-FLS (n = 3); (F) ROC curve of TDO2 in synovium was used to identify patients with OA. Data are presented as mean ± SEM. **P < 0.01 vs. control group, healthy subjects, or NSF group
TDO2 levels in synovium of OA and control groups. (A) Typical immunofluorescence images of TDO2 protein expression in synovium of the OA group (n = 5) and control group (n = 5) (magnification, 20 ×); (B) typical immunohistochemical images of TDO2 protein expression in synovium of OA (n = 5) and control (n = 5) groups (magnification, 40 ×); (C) typical western blot images and quantitative analysis of TDO2 protein expression in synovium of the OA (n = 3) and control (n = 3) groups; (D) expression level of TDO2 mRNA in synovium of OA patients (n = 10) and healthy subjects (n = 10) (Database